Building that plan into care from the beginning can prevent weight regain, improve long-term health improvements, and reduce ongoing costs
Key considerations include: Other diabetes medications Monitor for hypoglycaemia with sulphonylureas or insulin
Similarly, SGLT2 inhibitors have demonstrated robust cardiovascular and renal benefits, including reductions in cardiovascular events and all-cause mortality, with consistent effects across the drug class and irrespective of diabetes status [6, 7] Their metabolic benefitssuch as weight loss, improved lipid profiles, and reduced visceral adipositycontribute to a favourable cardiovascular risk profile, countering the pro-atherogenic state typical of T2DM [8]
[PMID: 28387721] PubMed record related to this compound for laboratory literature review
This creates a positive cycle where initial weight loss makes blood sugar easier to control, which in turn supports continued weight management